Physician profile
Jeffrey Lin
NPI 1528562006
$29,391.28
in general payments reported to CMS, 2019-2025
20 companies · $5,681 in 2025
The $5,681 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $12K · 2024: $12K · 2025: $5,681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Grant: $10K · Travel and Lodging: $9,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,221.13 |
| Grant | $10,000.00 |
| Travel and Lodging | $9,170.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18,970.21 | 2023-2025 | Synchromedii, Kyphon Express II Kyphopak Tray, Vanta Adaptivestim |
| Saluda Medical Americas, INC. | $2,726.92 | 2024-2025 | Evoke |
| Abbott Laboratories | $2,356.74 | 2024-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $2,137.28 | 2023-2025 | Superion Indirect Decompression System, General - Pain Management, Ams 700 |
| Nevro Corp. | $708.12 | 2023-2024 | Senza |
| Globus Medical, INC. | $664.81 | 2025 | Senza, Corridor |
| Spr Therapeutics, INC | $492.60 | 2023-2025 | Sprint Pns System |
| Avanos Medical | $282.23 | 2023-2025 | On-Q Pump and Accessories, Pnb and Accessories |
| Cook Medical LLC | $180.89 | 2025 | Profusion Therapeutic Infusion Needle, Ncircle |
| Nalu Medical, INC. | $165.42 | 2023-2024 | Nalu Neurostimulation System |
| Pacira Pharmaceuticals Incorporated | $155.06 | 2024 | Exparel |
| Heron Therapeutics, INC. | $120.86 | 2024 | Aponvie |
| Deciphera Pharmaceuticals INC. | $113.80 | 2025 | Romvimza, Qinlock |
| Averitas Pharma INC. | $108.13 | 2023 | Qutenza |
| Tempus Ai, INC | $78.98 | 2025 | Xt Cdx |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $45.47 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.95 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $24.84 | 2025 | |
| Janssen Biotech, INC. | $15.89 | 2024 | Stelara |
| Stryker Corporation | $15.08 | 2023 | Spinejack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.